Because GYS1 is the key enzyme catalyzing glycogen synthesis, we predicted that abnormal expression of GYS1 is involved in manipulating glycogen content and cellular bio-functional transformation in ccRCC. This evidence concerns the gene GYS1 and nonpapillary renal cell carcinoma.